Stocks · News reference

TD Cowen Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $420

Oct 13, 2026, 4:40 PMBenzinga Newsdesk

TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $410 to $420.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGAROct 26, 2026, 9:14 PMSEC EDGAR
8-K filing — WEST PHARMACEUTICAL SERVICES INC (WST)
Filed: 2026-10-26 AccNo: 0000105770-26-000114 Size: 59 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
WST
BenzingaOct 20, 2026, 4:19 PMBenzinga Newsdesk
Live On CNBC, Josh Brown Announces Bought West Pharmaceutical Services
WST
BenzingaOct 20, 2026, 6:54 AMBenzinga Newsdesk
Reported Earlier, West Pharmaceutical Raises Quarterly Dividend 18% To $0.26 Per Share From $0.22, Payable November 18 To Shareholders Of Record November 11
WST
BenzingaOct 19, 2026, 7:10 PMPiero Cingari
This 146-Old Can Maker Is On a Winning Streak Unseen In Its Half-Century Stock History
Ball Corp stock is on an 11-day winning streak, its longest since NYSE trading began in 1973, while the S&P 500 has slipped. Here is what the data shows.
APD BALL CCK LIN MAR